Evaluation of Rational Drug Use based on Indicators of Diseases and Facilities at Community Health Centers in Districts in Semarang

Nisa Febrinasari (1) , Abdur Rosyid (2) , Leny Angelina (3)
(1) Universitas Islam Sultan Agung , Indonesia
(2) Universitas Islam Sultan Agung , Indonesia
(3) Universitas Islam Sultan Agung , Indonesia

Abstract

Rational drug use (RDU) is an indicator to evaluates a treatment given to patients, like proper medication, precise diagnosis, precise dosing. Community Health Center (CHC) has the risk of irrational drug use. In this study, researchers selected N and BL CHC, aiming to evaluate the prescribing indicators based on three diseases which are non-pneumonia acute respiratory infection (ARI), non-specific diarrhea and myalgia, and the facility indicators with DOEN (list of essential national medicines) availability and 20 mandatory drugs. This research was a descriptive-analytical study with cross-sectional methods where the data retrieval of the prescribing is taken from January to December 2018. The study used the normality test and homogeneity test before independent sample T-test, from the third outcome of the test, the N and BL CHC could be said to differ significantly of RDU. It can be concluded that rational drug use is reviewed from a prescribing indicator based on disease and facility indicator. The results of RDU are rational in N CHC, in contrast with BL CHC which is not rational with the results of the RDU in N CHC is 101.44% and BL CHC is 89.81%. The results of N CHC is better than BL CHC, which both CHCs have fulfilled the target of the government, for 68% in 2018. In both CHCs for the facility indicator, there are a DOEN and 20 essential medicines.

Full text article

Generated from XML file

References

Read More

Authors

Nisa Febrinasari
nisafebrie@gmail.com (Primary Contact)
Leny Angelina
1.
Febrinasari N, Rosyid A, Angelina L. Evaluation of Rational Drug Use based on Indicators of Diseases and Facilities at Community Health Centers in Districts in Semarang. Borneo J Pharm [Internet]. 2019Nov.30 [cited 2025Apr.6];2(2):119-24. Available from: https://journal.umpr.ac.id/index.php/bjop/article/view/875

Article Details